• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4610432)   Today's Articles (7341)   Subscriber (49379)
For: Goz M, Eren MN, Cakir O. Arterial thrombosis and thalidomide. J Thromb Thrombolysis 2008;25:224-6. [PMID: 17514361 DOI: 10.1007/s11239-007-0057-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Number Cited by Other Article(s)
1
Alfredo MDAC, Schmitt JV, Miola AC, Milagres SDP, Lastoria JC. Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction. An Bras Dermatol 2024;99:53-56. [PMID: 37657956 DOI: 10.1016/j.abd.2023.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 12/15/2022] [Accepted: 01/09/2023] [Indexed: 09/03/2023]  Open
2
Watson N, Al-Samkari H. Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. J Thromb Haemost 2021;19:1852-1863. [PMID: 33928747 DOI: 10.1111/jth.15354] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2021] [Revised: 04/13/2021] [Accepted: 04/26/2021] [Indexed: 01/06/2023]
3
High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry. Blood Adv 2021;4:2139-2142. [PMID: 32421810 DOI: 10.1182/bloodadvances.2020001492] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2020] [Accepted: 04/08/2020] [Indexed: 01/24/2023]  Open
4
Atzori L, Ferreli C, Rongioletti F. Advances in understanding and treatment of scleromyxedema. Expert Opin Orphan Drugs 2018. [DOI: 10.1080/21678707.2018.1466700] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
5
Lee DH, Fradley MG. Cardiovascular Complications of Multiple Myeloma Treatment: Evaluation, Management, and Prevention. CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE 2018;20:19. [DOI: 10.1007/s11936-018-0618-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
6
Maharaj S, Chang S, Seegobin K, Serrano-Santiago I, Zuberi L. Increased risk of arterial thromboembolic events with combination lenalidomide/dexamethasone therapy for multiple myeloma. Expert Rev Anticancer Ther 2017;17:585-591. [PMID: 28508703 DOI: 10.1080/14737140.2017.1330153] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
7
Grima MA, Camilleri DJ. A Case of Internal Carotid Artery Thrombosis associated with Thalidomide Administration in Multiple Myeloma. Eur J Case Rep Intern Med 2016;3:000410. [PMID: 30755874 PMCID: PMC6346860 DOI: 10.12890/2016_000410] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2016] [Accepted: 03/09/2016] [Indexed: 11/23/2022]  Open
8
Cinotti E, Rongioletti F. Pharmacotherapy of scleromyxedema. Expert Opin Orphan Drugs 2013. [DOI: 10.1517/21678707.2013.839379] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
9
Hjorth M, Hjertner Ø, Knudsen LM, Gulbrandsen N, Holmberg E, Pedersen PT, Andersen NF, Andréasson B, Billström R, Carlson K, Carlsson MS, Flogegård M, Forsberg K, Gimsing P, Karlsson T, Linder O, Nahi H, Othzén A, Swedin A. Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study. Eur J Haematol 2012;88:485-96. [PMID: 22404182 PMCID: PMC3492844 DOI: 10.1111/j.1600-0609.2012.01775.x] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
10
High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study. Blood 2010;116:22-6. [DOI: 10.1182/blood-2009-12-257519] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
11
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood 2010;115:4991-8. [PMID: 20299513 DOI: 10.1182/blood-2009-11-252072] [Citation(s) in RCA: 168] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]  Open
12
Martin MG, Vij R. Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature. ACTA ACUST UNITED AC 2010;9:320-3. [PMID: 19717384 DOI: 10.3816/clm.2009.n.063] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
13
Multifocal Arterial Thrombosis during Thalidomide Therapy: Case Report and Review of the Literature. Case Rep Med 2009;2009:372073. [PMID: 19724648 PMCID: PMC2731312 DOI: 10.1155/2009/372073] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2009] [Accepted: 07/09/2009] [Indexed: 11/27/2022]  Open
14
Treatment of multiple myeloma and arterial thrombosis. Ann Hematol 2009;89:419-20. [DOI: 10.1007/s00277-009-0803-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2009] [Accepted: 07/29/2009] [Indexed: 10/20/2022]
15
Sidhu G, Soff GA. The coagulation system and angiogenesis. Cancer Treat Res 2009;148:67-80. [PMID: 19377919 DOI: 10.1007/978-0-387-79962-9_5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
16
Daher IN, Yeh ETH. Vascular complications of selected cancer therapies. ACTA ACUST UNITED AC 2008;5:797-805. [PMID: 18852710 DOI: 10.1038/ncpcardio1375] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2008] [Accepted: 09/08/2008] [Indexed: 11/09/2022]
17
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiol Drug Saf 2008. [DOI: 10.1002/pds.1491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA